{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:18:40Z","timestamp":1790475520379,"version":"4.1.0"},"reference-count":127,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007721","name":"Cure SMA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007721","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Miracles for Madison Fund"},{"DOI":"10.13039\/100012465","name":"Nemours Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012465","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Institute of Neurological Disorders and Stroke of the National Institutes of Health","award":["R01NS38650"],"award-info":[{"award-number":["R01NS38650"]}]},{"name":"National Institute of Neurological Disorders and Stroke of the National Institutes of Health","award":["R01NS069601"],"award-info":[{"award-number":["R01NS069601"]}]},{"name":"National Institute of General Medical Sciences of the National Institutes of Health","award":["P20GM103464"],"award-info":[{"award-number":["P20GM103464"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.expneurol.2016.02.009","type":"journal-article","created":{"date-parts":[[2016,2,15]],"date-time":"2016-02-15T20:50:18Z","timestamp":1455569418000},"page":"13-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Protective effects of butyrate-based compounds on a mouse model for spinal muscular atrophy"],"prefix":"10.1016","volume":"279","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2912-6400","authenticated-orcid":false,"given":"Matthew E.R.","family":"Butchbach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casey J.","family":"Lumpkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashlee W.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Saieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen","family":"Workman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise R.","family":"Simard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livio","family":"Pellizzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur H.M.","family":"Burghes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2016.02.009_bb0005","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/sj.ejhg.5201102","article-title":"Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy","volume":"12","author":"Andreassi","year":"2004","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0010","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1172\/JCI29562","article-title":"Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy","volume":"117","author":"Avila","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0015","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s002800000256","article-title":"Pharmacokinetics and cerebrospinal fluid penetration of phenylacetate and phenylbutyrate in the nonhuman primate","volume":"47","author":"Berg","year":"2001","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0020","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.1093\/hmg\/ddq300","article-title":"Early heart failure in the SMN\u03947 model of spinal muscular atrophy and correction by postnatal scAAV9-SMN delivery","volume":"19","author":"Bevan","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0025","doi-asserted-by":"crossref","first-page":"11288","DOI":"10.1523\/JNEUROSCI.1764-10.2010","article-title":"In vivo NMDA receptor activation accelerates motor unit maturation, protects spinal motor neurons and enhances SMN2 gene expression in severe spinal muscular atrophy mice","volume":"30","author":"Biondi","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0030","doi-asserted-by":"crossref","first-page":"5907","DOI":"10.1113\/jphysiol.2012.238196","article-title":"Physical exercise reduces cardiac defects in type 2 spinal muscular atrophy-like mice","volume":"590","author":"Biondi","year":"2012","journal-title":"J. Physiol."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0035","doi-asserted-by":"crossref","first-page":"12063","DOI":"10.1523\/JNEUROSCI.0608-15.2015","article-title":"IGF-1R reduction triggers neuroprotective signaling pathways in spinal muscular atrophy mice","volume":"35","author":"Biondi","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0040","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1016\/S0021-9258(17)34804-4","article-title":"Suppression of histone deacetylation in vivo and in vitro by sodium butyrate","volume":"253","author":"Boffa","year":"1978","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0045","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1093\/hmg\/ddq021","article-title":"Rho-kinase inactivation prolongs survival of an intermediate SMA mouse model","volume":"19","author":"Bowerman","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0050","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/sj.ejhg.5201320","article-title":"Phenylbutyrate increases SMN gene expression in spinal muscular atrophy patients","volume":"13","author":"Brahe","year":"2005","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0055","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.1523\/JNEUROSCI.2728-12.2013","article-title":"Shift from extracellular signal-related kinase to AKT\/cAMP response element-binding protein pathway increases survival-motor-neuron expression in spinal-muscular-atrophy-like mice and patient cells","volume":"33","author":"Branchu","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0060","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1093\/hmg\/ddg256","article-title":"Valproic acid increases the SMN2 protein level: a well-known drug as potential therapy for spinal muscular atrophy","volume":"12","author":"Brichta","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0065","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/ana.20836","article-title":"In vivo activation of SMN in spinal muscular atrophy carriers and patients treated with valproate","volume":"59","author":"Brichta","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0070","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.nbd.2007.04.009","article-title":"Abnormal motor phenotype in the SMN\u03947 mouse model of spinal muscular atrophy","volume":"27","author":"Butchbach","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0075","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jneumeth.2006.11.002","article-title":"A novel method for oral delivery of compounds to the neonatal SMN\u03947 model of spinal muscular atrophy","volume":"161","author":"Butchbach","year":"2007","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.expneurol.2016.02.009_bb0080","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.bbrc.2009.11.148","article-title":"Effect of diet on the survival and phenotype of a mouse model for spinal muscular atrophy","volume":"391","author":"Butchbach","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0085","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1093\/hmg\/ddp510","article-title":"Effects of 2,4-diaminoquinazoline derivatives on SMN expression and phenotype in a mouse model for spinal muscular atrophy","volume":"19","author":"Butchbach","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2014.03.005","article-title":"The effect of diet on the protective action of D156844 observed in spinal muscular atrophy mice","volume":"256","author":"Butchbach","year":"2014","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0095","doi-asserted-by":"crossref","first-page":"9808","DOI":"10.1073\/pnas.171105098","article-title":"Treatment of spinal muscular atrophy by sodium butyrate","volume":"98","author":"Chang","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0100","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1021\/cn200085z","article-title":"Identification of a maleimide-based glycogen synthase kinase-3 (GSK-3) inhibitor, BIP-135, that prolongs the median survival time of \u03947 SMA KO mouse model of spinal muscular atrophy","volume":"3","author":"Chen","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0105","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/emmm.201202305","article-title":"Enhancement of SMN protein levels in a mouse model of spinal muscular atrophy using novel drug-like compounds","volume":"5","author":"Cherry","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0110","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.tins.2009.06.002","article-title":"Multiple roles of HDAC inhibition in neurodegenerative conditions","volume":"32","author":"Chuang","year":"2009","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0115","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/hmg\/11.12.1439","article-title":"Neurofilament accumulation at the motor endplate and lack of axonal sprouting in a spinal muscular atrophy mouse model","volume":"11","author":"Cifuentes-Diaz","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0120","first-page":"629","article-title":"Phase I study of the orally administered butyrate prodrug, tributyrin, in patients with solid tumors","volume":"4","author":"Conley","year":"1998","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0125","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/hmg\/6.8.1205","article-title":"The survival motor neuron protein in spinal muscular atrophy","volume":"6","author":"Coovert","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0130","first-page":"4334","article-title":"Histone deacetylase inhibitors decrease proliferation and modulate cell cycle gene expression in normal mammary epithelial cells","volume":"6","author":"Davis","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0135","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/17482960802226148","article-title":"Combined riluzole and sodium phenylbutyrate therapy in transgenic amyotrophic lateral sclerosis mice","volume":"10","author":"Del Signore","year":"2009","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0140","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1101\/gr.7.4.339","article-title":"Cloning, characterization and copy number of the murine survival motor neuron gene: homolog of the spinal muscular atrophy-determining gene","volume":"7","author":"DiDonato","year":"1997","journal-title":"Genome Res."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0145","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/hmg\/ddq514","article-title":"Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice","volume":"20","author":"Dominguez","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0150","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00280-003-0580-5","article-title":"Clinical and pharmacologic study of tributyrin: an oral butyrate prodrug","volume":"51","author":"Edelman","year":"2003","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0155","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s002800050922","article-title":"Plasma pharmacokinetics of butyrate after intravenous administration of sodium butyrate or oral administration of tributyrin or sodium butyrate to mice and rats","volume":"43","author":"Egorin","year":"1999","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0160","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/mus.21350","article-title":"An analysis of disease severity based on SMN2 copy number in adults with spinal muscular atrophy","volume":"40","author":"Elsheikh","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.expneurol.2016.02.009_bb0165","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1523\/JNEUROSCI.23-28-09418.2003","article-title":"Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice","volume":"23","author":"Ferrante","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0170","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nbt.1610","article-title":"Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN","volume":"28","author":"Foust","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0175","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1093\/hmg\/ddi390","article-title":"The activity of the spinal muscular atrophy protein is regulated during development and cellular differentiation","volume":"14","author":"Gabanella","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0180","doi-asserted-by":"crossref","first-page":"e921","DOI":"10.1371\/journal.pone.0000921","article-title":"Ribonucleoprotein assembly defects correlate with spinal muscular atrophy severity and preferentially affect a subset of spliceosomal snRNPs","volume":"9","author":"Gabanella","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2016.02.009_bb0185","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1093\/hmg\/ddp313","article-title":"LBH589 induces up to 10-fold SMN protein levels by several independent mechanisms and is effective even in cells from SMA patients non-responsive to valproate","volume":"18","author":"Garbes","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0190","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1074\/jbc.M410210200","article-title":"Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease","volume":"280","author":"Gardian","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0195","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/hmg\/ddm379","article-title":"Neuronal SMN expression corrects spinal muscular atrophy in severe SMA mice while muscle specific SMN expression has no phenotypic effect","volume":"17","author":"Gavrilina","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0200","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.1093\/hmg\/ddt258","article-title":"The DcpS inhibitor RG3039 improves survival, function and motor unit pathologies in two SMA mouse models","volume":"22","author":"Gogliotti","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0205","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1471-4159.2006.03868.x","article-title":"In vitro and ex vivo evaluation of second-generation histone deacetylase inhibitors for the treatment of spinal muscular atrophy","volume":"98","author":"Hahnen","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0210","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.braindev.2011.04.010","article-title":"Valproic acid increases SMN2 expression and modulates SF2\/ASF and hnRNPA1 expression in SMA fibroblast cell lines","volume":"34","author":"Harahap","year":"2012","journal-title":"Brain Dev."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0215","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.nmd.2015.05.008","article-title":"The effect of the DcpS inhibitor D156844 on the protective action of follistatin in mice with spinal muscular atrophy","volume":"25","author":"Harris","year":"2015","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0220","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/hmg\/ddp030","article-title":"Translational readthrough by the aminoglycoside geneticin (G418) modulates SMN stability in vitro and improves motor function of SMA mice in vivo","volume":"18","author":"Heier","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0225","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1093\/hmg\/ddq330","article-title":"Arrhythmia and cardiac defects are a feature of spinal muscular atrophy model mice","volume":"19","author":"Heier","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0230","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/71709","article-title":"A mouse model for spinal muscular atrophy","volume":"24","author":"Hsieh-Li","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0235","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1101\/gad.1941310","article-title":"Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model","volume":"24","author":"Hua","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0240","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nature10485","article-title":"Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model","volume":"478","author":"Hua","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2016.02.009_bb0245","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nrn2870","article-title":"GSK3 signalling in neural development","volume":"11","author":"Hur","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0250","doi-asserted-by":"crossref","first-page":"6160","DOI":"10.1093\/hmg\/ddv332","article-title":"Low levels of survival motor neuron protein are sufficient for normal muscle function in the SMN\u03947 mouse model of SMA","volume":"24","author":"Iyer","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0255","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/hmg\/ddi130","article-title":"The role of histone acetylation in SMN gene expression","volume":"14","author":"Kernochan","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0260","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/sj.bjc.6601510","article-title":"Sodium butyrate and tributyrin induce in vivo growth inhibition and apoptosis in human prostate cancer","volume":"90","author":"Kuefer","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.expneurol.2016.02.009_bb0265","doi-asserted-by":"crossref","first-page":"6318","DOI":"10.1093\/hmg\/ddu350","article-title":"SMN regulates axonal local translation via miR-183\/mTOR pathway","volume":"23","author":"Kye","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0270","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/hmg\/ddi078","article-title":"SMN\u03947, the major product of the centromeric survival motor neuron gene (SMN2), extends survival in mice with spinal muscular atrophy and associates with full-length SMN","volume":"14","author":"Le","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0275","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2016.02.009_bb0280","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/ng0797-265","article-title":"Correlation between severity and SMN protein level in spinal muscular atrophy","volume":"16","author":"Lefebvre","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0285","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.semcdb.2014.04.026","article-title":"SMN control of RNP assembly: from post-transcriptional gene regulation to motor neuron disease","volume":"32","author":"Li","year":"2014","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0290","doi-asserted-by":"crossref","first-page":"e101225","DOI":"10.1371\/journal.pone.0101225","article-title":"The Smn-independent beneficial effects of trichostatin A on an intermediate mouse model of spinal muscular atrophy","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2016.02.009_bb0295","doi-asserted-by":"crossref","first-page":"6307","DOI":"10.1073\/pnas.96.11.6307","article-title":"A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy","volume":"96","author":"Lorson","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0300","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1111\/j.1471-4159.2009.06084.x","article-title":"The emerging role of epigenetic modifications and chromatin remodeling in spinal muscular atrophy","volume":"109","author":"Lunke","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0305","doi-asserted-by":"crossref","first-page":"8703","DOI":"10.1523\/JNEUROSCI.0204-12.2012","article-title":"Survival motor neuron protein in motor neurons determines synaptic integrity in spinal muscular atrophy","volume":"32","author":"Martinez","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0310","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1093\/hmg\/ddp333","article-title":"Delivery of a read-through inducing compound, TC007, lessens the severity of a SMA animal model","volume":"18","author":"Mattis","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0315","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/1471-2202-10-142","article-title":"Sucutaneous administration of TC007 reduces disease severity in an animal model of SMA","volume":"10","author":"Mattis","year":"2009","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0320","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neulet.2012.07.024","article-title":"Analysis of a read-through promoting compound in a severe mouse model of spinal muscular atrophy","volume":"525","author":"Mattis","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0325","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1086\/515465","article-title":"Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number","volume":"60","author":"McAndrew","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0330","first-page":"1232","article-title":"Pharmacokinetics and efficacy studies of a new butyrate prodrug for induction of fetal hemoglobin in anemic rhesus monkeys","volume":"88","author":"McCaffrey","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.expneurol.2016.02.009_bb0335","doi-asserted-by":"crossref","first-page":"5524","DOI":"10.1093\/hmg\/ddv283","article-title":"SMN expression is required in motor neurons to rescue electrophysiological deficits in the SMN\u03947 mouse model of SMA","volume":"24","author":"McGovern","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0340","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.neuron.2010.12.032","article-title":"Early functional impairment of sensory-motor connectivity in a mouse model of spinal muscular atrophy","volume":"69","author":"Mentis","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2016.02.009_bb0345","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.nmd.2003.11.006","article-title":"Pilot trial of phenylbutyrate in spinal muscular atrophy","volume":"14","author":"Mercuri","year":"2004","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0350","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1212\/01.wnl.0000249142.82285.d6","article-title":"Randomized, double-blind, placebo-controlled trial of phenylbutyrate in spinal muscular atrophy","volume":"68","author":"Mercuri","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2016.02.009_bb0355","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.nbd.2010.01.006","article-title":"Neuromuscular defects and breathing disorders in a new mouse model of spinal muscular atrophy","volume":"38","author":"Michaud","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0360","doi-asserted-by":"crossref","first-page":"e62114","DOI":"10.1371\/journal.pone.0062114","article-title":"Improved antisense oligonucleotide design to suppress aberrant SMN2 gene transcript processing: towards a treatment for spinal muscular atrophy","volume":"8","author":"Mitrpant","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2016.02.009_bb0365","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0378-4347(87)80376-6","article-title":"High-performance liquid chromatographic analysis of serum short-chain fatty acids by direct derivatization","volume":"421","author":"Miwa","year":"1987","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0370","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/hmg\/8.7.1177","article-title":"A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2","volume":"8","author":"Monani","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0375","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/hmg\/9.3.333","article-title":"The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn\u2212\/\u2212 mice and results in a mouse with spinal muscular atrophy","volume":"9","author":"Monani","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0380","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/ana.21449","article-title":"Sustained improvement of spinal muscular atrophy mice treated with trichostatin A plus nutrition","volume":"64","author":"Narver","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0385","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1126\/science.1250127","article-title":"SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy","volume":"345","author":"Naryshkin","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2016.02.009_bb0390","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1212\/01.wnl.0000313038.34337.b1","article-title":"A two-site ELISA can quantify upregulation of SMN protein by drugs for spinal muscular atrophy","volume":"71","author":"Nguyen thi Man","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2016.02.009_bb0395","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1083\/jcb.200210117","article-title":"Intact satellite cells lead to remarkable protection against Smn gene defect in differentiation skeletal muscle","volume":"161","author":"Nicole","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0400","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1093\/hmg\/ddq226","article-title":"PTEN depletion rescues axonal growth defect and improves survival in SMN-deficient motor neurons","volume":"19","author":"Ning","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0405","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1093\/hmg\/ddu198","article-title":"Morpholino antisense oligonucleotides targeting intronic repressor Element1 improve phenotype in SMA mouse models","volume":"23","author":"Osman","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0410","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1126\/science.1128294","article-title":"Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes","volume":"313","author":"\u00d6zcan","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2016.02.009_bb0415","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nchembio.1837","article-title":"SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice","volume":"11","author":"Palacino","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0420","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1172\/JCI41615","article-title":"CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy","volume":"120","author":"Passini","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0425","doi-asserted-by":"crossref","first-page":"72ra18","DOI":"10.1126\/scitranslmed.3001777","article-title":"Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophy","volume":"3","author":"Passini","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0430","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.nbd.2005.09.013","article-title":"Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis","volume":"22","author":"Petri","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0435","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s12035-013-8507-6","article-title":"Specific induction of Akt3 in spinal cord motor neurons is neuroprotective in a mouse model of familial amyotrophic lateral sclerosis","volume":"49","author":"Peviani","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0440","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/hmg\/ddr600","article-title":"A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse","volume":"21","author":"Porensky","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0445","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/ajmg.a.30251","article-title":"Homozygous SMN1 deletions in unaffected family members and modification of the phenotype by SMN2","volume":"130A","author":"Prior","year":"2005","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0450","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1124\/mol.104.001339","article-title":"Sodium 4-phenylbutyrate protects against cerebral ischemic injury","volume":"66","author":"Qi","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0455","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4161\/auto.6.2.11062","article-title":"ER stress negatively regulates AKT\/TSC\/mTOR pathway to enhance autophagy","volume":"6","author":"Qin","year":"2010","journal-title":"Autophagy"},{"key":"10.1016\/j.expneurol.2016.02.009_bb0460","doi-asserted-by":"crossref","first-page":"6231","DOI":"10.1038\/sj.onc.1206646","article-title":"Inhibition of PI-3 kinase sensitizes human leukemic cells to histone deacetylase inhibitor-mediated apoptosis through p44\/42 MAP kinase inactivation and abrogation of p21CIP1\/WAF1 induction rather than AKT inhibition","volume":"22","author":"Rahmani","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.expneurol.2016.02.009_bb0465","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3233\/JND-150081","article-title":"Spinal muscular atrophy biomarker measurements from blood samples in a clinical trial of valproic acid in ambulatory adults","volume":"2","author":"Renusch","year":"2015","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0470","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1038\/npp.2008.229","article-title":"Phenylbutyrate ameliorates cognitive deficit and reduces tau pathology in an Alzheimer's disease mouse model","volume":"34","author":"Ribobaraza","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.expneurol.2016.02.009_bb0475","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00439-006-0186-1","article-title":"The benzamide M344, a novel histone deacetylase inhibitor, significantly increases SMN2 RNA\/protein levels in spinal muscular atrophy cells","volume":"120","author":"Riessland","year":"2006","journal-title":"Hum. Genet."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0480","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1093\/hmg\/ddq023","article-title":"SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy","volume":"19","author":"Riessland","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0485","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0736-5748(02)00047-3","article-title":"Functions of PI 3-kinase in development of the nervous system","volume":"20","author":"Rodgers","year":"2002","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0490","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/hmg\/ddn426","article-title":"Delivery of recombinant follistatin lessens disease severity in a mouse model of spinal muscular atrophy","volume":"18","author":"Rose","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0495","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/j.1471-4159.2005.03077.x","article-title":"Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice","volume":"93","author":"Ryu","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0500","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1002\/emmm.201302567","article-title":"Pathological impact of SMN2 mis-splicing in adult SMA mice","volume":"5","author":"Sahashi","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0505","doi-asserted-by":"crossref","first-page":"9920","DOI":"10.1073\/pnas.94.18.9920","article-title":"Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos","volume":"94","author":"Schrank","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0510","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1093\/hmg\/ddq329","article-title":"Cardiac defects contribute to the pathology of spinal muscular atrophy models","volume":"19","author":"Shababi","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0515","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.yjmcc.2012.01.005","article-title":"Partial restoration of cardio-vascular defects in a rescued severe model of spinal muscular atrophy","volume":"52","author":"Shababi","year":"2012","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0520","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1212\/01.wnl.0000252934.70676.ab","article-title":"Preclinical validation of a multiplex real-time assay to quantify SMN mRNA in patients with SMA","volume":"68","author":"Simard","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2016.02.009_bb0525","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/mgg3.141","article-title":"SMN1 and SMN2 copy numbers in cell lines derived from patients with spinal muscular atrophy as measured by array digital PCR","volume":"3","author":"Stabley","year":"2015","journal-title":"Mol. Genet. Genomic Med."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0530","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ygeno.2015.01.007","article-title":"Rescue of gene-expression changes in an induced mouse model of spinal muscular atrophy by an antisense oligonucleotide that promotes inclusion of SMN2 exon 7","volume":"105","author":"Staropoli","year":"2015","journal-title":"Genomics"},{"key":"10.1016\/j.expneurol.2016.02.009_bb0535","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/35099568","article-title":"Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila","volume":"413","author":"Steffan","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2016.02.009_bb0540","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/ana.10743","article-title":"Valproic acid increases SMN levels in spinal muscular atrophy patient cells","volume":"54","author":"Sumner","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0545","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/ana.20473","article-title":"Natural history of denervation in SMA: relation to age, SMN2 copy number and function","volume":"57","author":"Swoboda","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0550","doi-asserted-by":"crossref","first-page":"e5268","DOI":"10.1371\/journal.pone.0005268","article-title":"Phase II open label study of valproic acid in spinal muscular atrophy","volume":"4","author":"Swoboda","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2016.02.009_bb0555","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1021\/jm061475p","article-title":"Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy","volume":"51","author":"Thurmond","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0560","doi-asserted-by":"crossref","first-page":"8691","DOI":"10.1523\/JNEUROSCI.0417-15.2015","article-title":"Disease mechanisms and therapeutic approaches in spinal muscular atrophy","volume":"35","author":"Tisdale","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0565","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.nmd.2007.02.006","article-title":"The Hammersmith functional score correlates with the SMN2 copy number: a multicentric study","volume":"17","author":"Tiziano","year":"2007","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0570","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s00109-008-0388-1","article-title":"Multiple therapeutic effects of valproic acid in spinal muscular atrophy model mice","volume":"86","author":"Tsai","year":"2008","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0575","doi-asserted-by":"crossref","first-page":"35ra42","DOI":"10.1126\/scitranslmed.3000830","article-title":"Systemic delivery of scAAV9 expressin SMN prolongs survival in a model of spinal muscular atrophy","volume":"2","author":"Valori","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0580","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1093\/hmg\/ddt257","article-title":"The DcpS inhibitor RG3039 improves motor function in SMA mice","volume":"22","author":"Van Meerbeke","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0585","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2002-3-7-research0034","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes","volume":"3","author":"Vandesompele","year":"2002","journal-title":"Genome Biol."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0590","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1006\/geno.1996.4551","article-title":"cDNA isolation, expression and chromosomal localization of the mouse survival motor neuron gene (Smn)","volume":"40","author":"Viollet","year":"1997","journal-title":"Genomics"},{"key":"10.1016\/j.expneurol.2016.02.009_bb0595","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/S0002-9440(10)63428-1","article-title":"Deletion of murine Smn exon 7 directed to liver leads to severe defect of liver development associated with iron overload","volume":"165","author":"Vitte","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0600","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1212\/01.wnl.0000231139.26253.d0","article-title":"Valproate may improve strength and function in patients with type III\/IV spinal muscular atrophy","volume":"67","author":"Weihl","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2016.02.009_bb0605","doi-asserted-by":"crossref","first-page":"7633","DOI":"10.1523\/JNEUROSCI.0950-09.2009","article-title":"Oligonucleotide-mediated survival of motor neuron protein expression in CNS improves phenotype in a mouse model of spinal muscular atrophy","volume":"29","author":"Williams","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0610","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s00439-006-0156-7","article-title":"Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number","volume":"119","author":"Wirth","year":"2006","journal-title":"Hum. Genet."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0615","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1002\/j.1460-2075.1990.tb07419.x","article-title":"Molecular cloning and expression glycogen synthase kinase-3\/factor A","volume":"9","author":"Woodgett","year":"1990","journal-title":"EMBO J."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0620","doi-asserted-by":"crossref","first-page":"12580","DOI":"10.1074\/jbc.M511677200","article-title":"Sodium butyrate ameliorates histone hypoacetylation and neurodegenerative phenotypes in a mouse model for DRPLA","volume":"281","author":"Ying","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0625","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1006\/excr.2000.4858","article-title":"The relationship between SMN, the spinal muscular atrophy protein, and nuclear coiled bodies in differentiated tissues and cultured cells","volume":"256","author":"Young","year":"2000","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.expneurol.2016.02.009_bb0630","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.cell.2008.03.031","article-title":"SMN deficiency causes tissue-specific perturbations in the repertoire of snRNAs and widespread defects in splicing","volume":"133","author":"Zhang","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2016.02.009_bb0635","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1089\/hum.2012.211","article-title":"A novel morpholino oligomer targeting ISS-N1 improves rescue of severe spinal muscular atrophy transgenic mice","volume":"24","author":"Zhou","year":"2013","journal-title":"Hum. Gene Ther."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488616300310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488616300310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T06:06:52Z","timestamp":1654322812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488616300310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":127,"alternative-id":["S0014488616300310"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2016.02.009","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective effects of butyrate-based compounds on a mouse model for spinal muscular atrophy","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2016.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}